About OBSOLETE: Tauopathy with a major tau triplet at 60, 64 and 69 kDa
OBSOLETE: Tauopathy with a major tau triplet at 60, 64 and 69 kDa is a rare disease catalogued by Orphanet (ORPHA:98529). Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries worldwide.
Clinical Trial Eligibility Tips
What to know before applying to OBSOLETE: Tauopathy with a major tau triplet at 60, 64 and 69 kDa trials.
Search ClinicalTrials.gov for "OBSOLETE: Tauopathy with a major tau triplet at 60, 64 and 69 kDa" or Orphanet code ORPHA:98529 to find disease-specific recruiting studies.
Ask your specialist to refer you to an Orphanet-accredited Centre of Expertise for this condition.
Natural history studies and patient registries often open enrolment before drug trials — contact the Orphanet patient community first.
Patient Resources
Find recruiting OBSOLETE: Tauopathy with a major tau triplet at 60, 64 and 69 kDa trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for OBSOLETE: Tauopathy with a major tau triplet at 60, 64 and 69 kDa. Updated daily.